{"abstract":"The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/08/17/2026-16716.html","cfr_references":[],"citation":"91 FR 53268","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":["Docket Nos. FDA-2025-N-1560","FDA-2021-N-1351","FDA-2025-N-2549","FDA-2025-N-0426","FDA-2026-N-0746","FDA-2026-N-0497","FDA-2025-N-0953","FDA-2024-N-4467","FDA-2025-N-4942","FDA-2025-N-2195","FDA-2025-N-0354","FDA-2025-N-3215","FDA-2025-N-1108","FDA-2025-N-0419","FDA-2025-N-1210","FDA-2025-N-0414","FDA-2025-N-1115","FDA-2025-N-1109","FDA-2025-N-1330","FDA-2024-N-5943","FDA-2025-N-0351","FDA-2025-N-3656","FDA-2025-N-2220","FDA-2024-N-5890","FDA-2012-D-0429","FDA-2025-N-0348","FDA-2025-N-1812","FDA-2025-N-2548","FDA-2025-N-4348","FDA-2024-N-1055","FDA-2025-N-0615","FDA-2024-N-3762","FDA-2023-N-0894","FDA-2025-N-0308","FDA-2024-N-0668","FDA-2025-N-1732"],"dockets":[{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:55.607-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2012-D-0429-0027","allow_late_comments":false,"id":"FDA-2012-D-0429-0027","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2012-D-0429","title":"Guidance on Meetings with Industry and Investigators on the Research and Development of Tobacco Products"},{"supporting_documents":[{"title":"Reference 8 - NDC-FRIA 2-20-26","document_id":"FDA-2021-N-1351-0064"},{"title":"Reference 7 - RTI (2015) Labeling Cost Model","document_id":"FDA-2021-N-1351-0063"},{"title":"Reference 6 - RAND Corp (2004)","document_id":"FDA-2021-N-1351-0062"},{"title":"Reference 5 - PRIA NDC Proposed Rule","document_id":"FDA-2021-N-1351-0061"},{"title":"Reference 4 - Nara S (2023)","document_id":"FDA-2021-N-1351-0060"},{"title":"Reference 3 - Carreiras M (2015)","document_id":"FDA-2021-N-1351-0059"},{"title":"Reference 2 - Molinaro (2010)","document_id":"FDA-2021-N-1351-0058"},{"title":"Reference 1 - Grissinger M (2017)","document_id":"FDA-2021-N-1351-0057"},{"title":"References 5 - RAND (2004), \"The Costs and Benefits of Moving to the ICD-10 Code Sets\"","document_id":"FDA-2021-N-1351-0008"},{"title":"References 4 - FDA, Preliminary Regulatory Impact Analysis, ‘‘Revising the National Drug Code Format and Drug Label Barcode Requirements\"","document_id":"FDA-2021-N-1351-0007"}],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:54.195-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2021-N-1351-0065","allow_late_comments":false,"id":"FDA-2021-N-1351-0065","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":13,"id":"FDA-2021-N-1351","title":"Revising the National Drug Code Format and Drug Label Barcode Requirements"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:59.355-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2024-N-0668-0008","allow_late_comments":false,"id":"FDA-2024-N-0668-0008","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2024-N-0668","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Proposed Small Dispensers Assessment under the Drug Supply Chain Security Act"},{"supporting_documents":[{"title":"Wireframe Tobacco Ingredients Manufacturer Form 3742","document_id":"FDA-2024-N-5943-0021"},{"title":"Wireframe Tobacco Ingredients  Importer Form 3742","document_id":"FDA-2024-N-5943-0020"},{"title":"Wireframe Current TRLM NG Industry Creating a New Registration","document_id":"FDA-2024-N-5943-0019"},{"title":"Wireframe Current Registration and Listing Site","document_id":"FDA-2024-N-5943-0018"},{"title":"NEW_ Form_FDA_3741","document_id":"FDA-2024-N-5943-0017"},{"title":"Net Changes from previous 3741 version","document_id":"FDA-2024-N-5943-0016"},{"title":"Form FDA-3742_031925","document_id":"FDA-2024-N-5943-0015"},{"title":"Current Form FDA 3741a Dockets","document_id":"FDA-2024-N-5943-0014"},{"title":"Current FDA Form 3741 Dockets","document_id":"FDA-2024-N-5943-0013"},{"title":"0650 Form FDA 3741b TRLMNGUploadTemplate_v2.39_AA","document_id":"FDA-2024-N-5943-0012"}],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:53.162-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2024-N-5943-0022","allow_late_comments":false,"id":"FDA-2024-N-5943-0022","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":19,"id":"FDA-2024-N-5943","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Tobacco Product Establishment Registration and Listing"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:55.243-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-0308-0004","allow_late_comments":false,"id":"FDA-2025-N-0308-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-0308","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Emerging Drug Safety Technology Meeting Program"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:55.971-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-0351-0004","allow_late_comments":false,"id":"FDA-2025-N-0351-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-0351","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Tobacco Health Document Submission"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:57:00.389-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-0354-0006","allow_late_comments":false,"id":"FDA-2025-N-0354-0006","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-0354","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:52.813-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-0419-0004","allow_late_comments":false,"id":"FDA-2025-N-0419-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-0419","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Device Reporting"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:57:00.027-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-0426-0004","allow_late_comments":false,"id":"FDA-2025-N-0426-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-0426","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Agreement for Shipment of Devices for Sterilization"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:53.846-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-0615-0003","allow_late_comments":false,"id":"FDA-2025-N-0615-0003","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-0615","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for Quick Turnaround Testing of Communication Effectiveness"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:54.525-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-0953-0004","allow_late_comments":false,"id":"FDA-2025-N-0953-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-0953","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Export of Medical Devices; Foreign Letters of Approval"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:58.695-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-1108-0003","allow_late_comments":false,"id":"FDA-2025-N-1108-0003","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-1108","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; 510(k) Third-Party Review Program"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T11:56:33.655-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-1210-0005","allow_late_comments":false,"id":"FDA-2025-N-1210-0005","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-1210","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarket  Surveillance of Medical Devices"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:52.491-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-1330-0005","allow_late_comments":false,"id":"FDA-2025-N-1330-0005","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-1330","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Submissions of Medical Device Registration and Listing"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:56.981-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-1560-0003","allow_late_comments":false,"id":"FDA-2025-N-1560-0003","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-1560","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Products"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:52.167-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-1812-0004","allow_late_comments":false,"id":"FDA-2025-N-1812-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-1812","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Q-Submission and Early Payor Feedback Request Programs and Medical Device Development Tools"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:57.626-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-2195-0005","allow_late_comments":false,"id":"FDA-2025-N-2195-0005","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-2195","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Humanitarian Use Devices"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:53.503-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-2220-0004","allow_late_comments":false,"id":"FDA-2025-N-2220-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-2220","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:59.679-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-2549-0005","allow_late_comments":false,"id":"FDA-2025-N-2549-0005","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-2549","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational Device Exemptions Reports and Records"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:58.352-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-3215-0004","allow_late_comments":false,"id":"FDA-2025-N-3215-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-3215","title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; FDA Food Safety and Nutrition Survey"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:59.015-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-3656-0004","allow_late_comments":false,"id":"FDA-2025-N-3656-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-3656","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:58.011-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-4348-0009","allow_late_comments":false,"id":"FDA-2025-N-4348-0009","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-4348","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:56.659-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2025-N-4942-0004","allow_late_comments":false,"id":"FDA-2025-N-4942-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2025-N-4942","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Mammography Standards Quality Act Requirements"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:56.339-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2026-N-0497-0004","allow_late_comments":false,"id":"FDA-2026-N-0497-0004","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2026-N-0497","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2026-08-17","updated_at":"2026-08-17T12:56:57.306-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2026-N-0746-0006","allow_late_comments":false,"id":"FDA-2026-N-0746-0006","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2026-N-0746","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program"}],"document_number":"2026-16716","effective_on":null,"end_page":53269,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/08/17/2026-16716.xml","html_url":"https://www.federalregister.gov/documents/2026/08/17/2026-16716/agency-information-collection-activities-announcement-of-office-of-management-and-budget-approvals","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-16716?publication_date=2026-08-17","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-08-17/2026-16716/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":307,"last_updated":"2026-09-21 04:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-08-17/pdf/2026-16716.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-16716.pdf?1786711513","publication_date":"2026-08-17","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/08/17/2026-16716.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2025-N-1812","supporting_documents_count":0,"docket_id":"FDA-2025-N-1812","document_id":"FDA-2025-N-1812-0004","regulation_id_number":null,"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Q-Submission and Early Payor Feedback Request Programs and Medical Device Development Tools","checked_regulationsdotgov_at":"2026-08-18T19:56:52Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":53268,"subtype":null,"title":"Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals","toc_doc":"Agency Information Collection Activities; Proposals, Submissions, and Approvals","toc_subject":null,"topics":[],"type":"Notice","volume":91}